Approval · Notice of Compliance 1149 · 2000
FORADIL: Notice of Compliance 1149
Issued December 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1149
- Date
- December 1, 2000
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: treatment of asthma in patients 6 years of age and older with reversible obstructive airways disease
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FORADIL | Not yet assigned | — |
Medicinal ingredients
- FORMOTEROL FUMARATE 12 MCG per CAP